发明名称 |
Selective Estrogen Receptor Modulators With Short Half-Lives and Uses Thereof |
摘要 |
The present invention relates to the long-term administration of a selective estrogen receptor modulator (SERM) with a short half-life for the treatment of a variety of estrogen receptor-mediated conditions. The SERM may be administered at a concentration at or below that of a SERM with a long half-life in order to achieve an equivalent therapeutic effect. |
申请公布号 |
US2015031680(A1) |
申请公布日期 |
2015.01.29 |
申请号 |
US201314378573 |
申请日期 |
2013.02.14 |
申请人 |
REPROS THERAPEUTICS INC. |
发明人 |
Podolski Joseph S.;Wiehle Ronald D. |
分类号 |
A61K31/55;A61K31/4025;A61K31/4535;A61K31/138 |
主分类号 |
A61K31/55 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating an estrogen receptor-mediated condition comprising administering a selective estrogen receptor modulator (SERM) or a pharmaceutically acceptable salt thereof selected from the group consisting of droloxifene, levormeloxifene, (Deaminohydroxy)toremifene, raloxifene, bazedoxifene and arzoxifene for a period of at least 6 months at a dosage of between 1 and 19 mg per day or every other day to a patient in need of such treatment. |
地址 |
The Woodlands TX US |